Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
3,415
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
3,415
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
2020-11-08 17:00 | Report Abuse
“ No reason to say mink-related coronavirus mutation will harm vaccine development: WHO Europe chief
On Friday, experts from the Geneva-based WHO also said that there is no evidence at the moment that the mutation of SARS-CoV-2 virus in minks in Denmark will affect the efficacy of future vaccines for COVID-19.”
http://famagusta-gazette.com/2020/11/08/no-reason-to-say-mink-related-coronavirus-mutation-will-harm-vaccine-development-who-europe-chief/
Stock
2020-11-08 17:00 | Report Abuse
“ No reason to say mink-related coronavirus mutation will harm vaccine development: WHO Europe chief
On Friday, experts from the Geneva-based WHO also said that there is no evidence at the moment that the mutation of SARS-CoV-2 virus in minks in Denmark will affect the efficacy of future vaccines for COVID-19.”
http://famagusta-gazette.com/2020/11/08/no-reason-to-say-mink-related-coronavirus-mutation-will-harm-vaccine-development-who-europe-chief/
Stock
2020-11-08 16:58 | Report Abuse
@Savvy88 No need to worry at all. There is no evidence.
“ No reason to say mink-related coronavirus mutation will harm vaccine development: WHO Europe chief
On Friday, experts from the Geneva-based WHO also said that there is no evidence at the moment that the mutation of SARS-CoV-2 virus in minks in Denmark will affect the efficacy of future vaccines for COVID-19.”
http://famagusta-gazette.com/2020/11/08/no-reason-to-say-mink-related-coronavirus-mutation-will-harm-vaccine-development-who-europe-chief/
Stock
2020-11-08 16:53 | Report Abuse
@Savvy88 No need to worry at all. There is no evidence.
“ No reason to say mink-related coronavirus mutation will harm vaccine development: WHO Europe chief
On Friday, experts from the Geneva-based WHO also said that there is no evidence at the moment that the mutation of SARS-CoV-2 virus in minks in Denmark will affect the efficacy of future vaccines for COVID-19.”
http://famagusta-gazette.com/2020/11/08/no-reason-to-say-mink-related-coronavirus-mutation-will-harm-vaccine-development-who-europe-chief/
Stock
2020-11-08 01:45 | Report Abuse
Could a Joe Biden presidency and a blocking Republican Senate be the perfect recipe for global share markets?
So far, the evidence is fairly strong that this gridlock scenario is hitting just the right spot for investors with the Australian market up an impressive 4.4 % for the week even before there was absolute clarity about the electoral outcome.
The reason this seems to be the dream scenario is that Biden’s more controversial economic policies such as tax rises for the wealthy, big spending plans and regulatory reforms now seem certain to be blocked in the US Senate but he also now seems set to replace Donald Trump as President, resulting in a more stable and predictable White House.
In particular, Joe Biden is seen as being a safer pair of hands for handling delicate trade and foreign policy issues.
https://smallcaps.com.au/biden-president-republican-senate-perfect-market-recipe-weekly-review/
Stock
2020-11-08 01:45 | Report Abuse
Could a Joe Biden presidency and a blocking Republican Senate be the perfect recipe for global share markets?
So far, the evidence is fairly strong that this gridlock scenario is hitting just the right spot for investors with the Australian market up an impressive 4.4 % for the week even before there was absolute clarity about the electoral outcome.
The reason this seems to be the dream scenario is that Biden’s more controversial economic policies such as tax rises for the wealthy, big spending plans and regulatory reforms now seem certain to be blocked in the US Senate but he also now seems set to replace Donald Trump as President, resulting in a more stable and predictable White House.
In particular, Joe Biden is seen as being a safer pair of hands for handling delicate trade and foreign policy issues.
https://smallcaps.com.au/biden-president-republican-senate-perfect-market-recipe-weekly-review/
Stock
2020-11-08 01:41 | Report Abuse
Kanger will certainly benefit from Biden win.
"The stocks to buy now Joe Biden has won the US election
CHINESE STOCKS
Mr Biden would likely pursue a less adversarial approach towards China, which could benefit Chinese stocks, particularly those growing their customer bases in America, said Mr Danis. A number of large Chinese businesses are already expanding overseas and starting to steal market share from the Silicon Valley tech giants.
This includes retailer Alibaba and software company Tencent, both of which can be owned via the £1.8bn Fidelity China Special Situations investment trust. "
https://www.telegraph.co.uk/investing/shares/stocks-buy-now-joe-biden-has-won-us-election/
Stock
2020-11-08 01:23 | Report Abuse
@cincaruk. Its Constellation Holdings Ltd. Can refer to this article for further info.
https://www.theedgemarkets.com/article/kanger-courted-uae-firm-jointly-set-glove-outfit-malaysia
Stock
2020-11-08 01:15 | Report Abuse
@sepolcmd If the proceeds of private placement areused to grow the company’s business and profit , it Is a good thing. If it Is used to pay debts, then it Is bad . In this case its the former, so it Is good and i dont mind at all.
Stock
2020-11-08 01:11 | Report Abuse
Biden 46th president. Prlexus will fly to Pluto soon.
Stock
2020-11-08 01:08 | Report Abuse
Biden 46th president. Prlexus will fly to Pluto soon.
Stock
2020-11-07 22:23 | Report Abuse
@Noobie123 Actually, the vaccine needs to be approved by China first before it can be pre-qualified by WHO. WHO pre-qualification is one of the conditions for WHO emergency use listing of vaccines which has currently been obtained by Sinopharm based on phase II and ongoing phase III clinical data. This means that once the phase III clinical trial is complete, and the Covid vaccine has been approved by China Food and Drug Administration, Sinopharm is obliged to submit the complete phase III clinical data to WHO for the purpose of pre-qualification.
Stock
2020-11-07 21:08 | Report Abuse
None of the 56,000 people who were inoculated with a COVID-19 vaccine and travelled abroad have contracted the coronavirus, Sinopharm's chairman said on Friday.
Sinopharm Chairman Liu Jingzhen, said at a conference on Friday that some 100,000 people have been vaccinated with the company's vaccine and have shown none adverse reactions so far. Among those who were inoculated and travelled aboard, none have been infected with the virus, said Liu.
https://www.globaltimes.cn/content/1206008.shtml
Stock
2020-11-07 16:37 | Report Abuse
@ikanbilisjerungwnabe It is not a rumour. Its stated in the news. The links are as follows for your reading pleasure. Thanks
https://www.nst.com.my/business/2020/10/632004/kanger-boosted-malaysia-chinas-priority-vaccine-recipient-list
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 16:31 | Report Abuse
@Friendship Did Titijaya sign agreement with Sinopharm for Vaccine distribution? Can you share the link? Thanks
Stock
2020-11-07 16:01 | Report Abuse
FYI Kanger will be collaborating with Zuellig Pharma for the distribution. Zuellig Pharma has experience distributing vaccines in Malaysia and has been inspected for Good Distribution Practice of cold chain products by the ministry of health Malaysia. Zuellig Pharma's distribution network covers almost all of Malaysia’s hospitals, clinics and pharmacies, including Ministry of Health facilities.
Stock
2020-11-07 02:33 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:33 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:31 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:30 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:30 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:29 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:29 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:28 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:27 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:26 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:25 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:25 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:24 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:23 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:23 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:22 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:21 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:21 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:21 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:20 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:20 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:19 | Report Abuse
Sinopharm has experience with WHO pre-qualification for vaccines. Hence, it should be an issue obtaining WHO pre-qualification for Sinopharm Covid Vaccine (Linked to Kanger).
"Sinopharm and Sinovac both have other vaccines pre-qualified by the WHO. A subsidiary of Sinopharm was the first to receive WHO prequalification for Japanese encephalitis vaccines after years of support from several UN agencies to help it meet the standard. “They know what the WHO wants,” Kim said, adding that China was supplying 80 per cent of the Japanese encephalitis vaccines in Asia."
https://www.scmp.com/news/china/science/article/3107191/can-china-become-leading-producer-covid-19-vaccines
Stock
2020-11-07 02:18 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 02:08 | Report Abuse
Sinopharm has experience with WHO pre-qualification for vaccines. Hence, it should be an issue obtaining WHO pre-qualification for Sinopharm Covid Vaccine.
"Sinopharm and Sinovac both have other vaccines pre-qualified by the WHO. A subsidiary of Sinopharm was the first to receive WHO prequalification for Japanese encephalitis vaccines after years of support from several UN agencies to help it meet the standard. “They know what the WHO wants,” Kim said, adding that China was supplying 80 per cent of the Japanese encephalitis vaccines in Asia."
https://www.scmp.com/news/china/science/article/3107191/can-china-become-leading-producer-covid-19-vaccines
Stock
2020-11-07 02:07 | Report Abuse
Sinopharm has experience with WHO pre-qualification for vaccines. Hence, it should be an issue obtaining WHO pre-qualification for Sinopharm Covid Vaccine.
"Sinopharm and Sinovac both have other vaccines pre-qualified by the WHO. A subsidiary of Sinopharm was the first to receive WHO prequalification for Japanese encephalitis vaccines after years of support from several UN agencies to help it meet the standard. “They know what the WHO wants,” Kim said, adding that China was supplying 80 per cent of the Japanese encephalitis vaccines in Asia."
https://www.scmp.com/news/china/science/article/3107191/can-china-become-leading-producer-covid-19-vaccines
Stock
2020-11-07 02:07 | Report Abuse
Sinopharm has experience with WHO pre-qualification for vaccines. Hence, it should be an issue obtaining WHO pre-qualification for Sinopharm Covid Vaccine.
"Sinopharm and Sinovac both have other vaccines pre-qualified by the WHO. A subsidiary of Sinopharm was the first to receive WHO prequalification for Japanese encephalitis vaccines after years of support from several UN agencies to help it meet the standard. “They know what the WHO wants,” Kim said, adding that China was supplying 80 per cent of the Japanese encephalitis vaccines in Asia."
https://www.scmp.com/news/china/science/article/3107191/can-china-become-leading-producer-covid-19-vaccines
Stock
2020-11-07 02:06 | Report Abuse
Sinopharm has experience with WHO pre-qualification for vaccines. Hence, it should be an issue obtaining WHO pre-qualification for Sinopharm Covid Vaccine.
"Sinopharm and Sinovac both have other vaccines pre-qualified by the WHO. A subsidiary of Sinopharm was the first to receive WHO prequalification for Japanese encephalitis vaccines after years of support from several UN agencies to help it meet the standard. “They know what the WHO wants,” Kim said, adding that China was supplying 80 per cent of the Japanese encephalitis vaccines in Asia."
https://www.scmp.com/news/china/science/article/3107191/can-china-become-leading-producer-covid-19-vaccines
Stock
2020-11-07 02:06 | Report Abuse
Sinopharm has experience with WHO pre-qualification for vaccines. Hence, it should be an issue obtaining WHO pre-qualification for Sinopharm Covid Vaccine.
"Sinopharm and Sinovac both have other vaccines pre-qualified by the WHO. A subsidiary of Sinopharm was the first to receive WHO prequalification for Japanese encephalitis vaccines after years of support from several UN agencies to help it meet the standard. “They know what the WHO wants,” Kim said, adding that China was supplying 80 per cent of the Japanese encephalitis vaccines in Asia."
https://www.scmp.com/news/china/science/article/3107191/can-china-become-leading-producer-covid-19-vaccines
Stock
2020-11-07 01:47 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 01:46 | Report Abuse
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 01:44 | Report Abuse
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock
2020-11-07 01:44 | Report Abuse
Maybe, but it will be a long wait until 2022 which is the estimated date of completion of phase III trials.
Stock
2020-11-07 01:42 | Report Abuse
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
Stock: [SOLUTN]: SOLUTION GROUP BERHAD
2020-11-08 17:02 | Report Abuse
@Savvy88 No need to worry at all. There is no evidence.
“ No reason to say mink-related coronavirus mutation will harm vaccine development: WHO Europe chief
On Friday, experts from the Geneva-based WHO also said that there is no evidence at the moment that the mutation of SARS-CoV-2 virus in minks in Denmark will affect the efficacy of future vaccines for COVID-19.”
http://famagusta-gazette.com/2020/11/08/no-reason-to-say-mink-related-coronavirus-mutation-will-harm-vaccine-development-who-europe-chief/